The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lazorchak, A. S.
Right arrow Articles by Zhuang, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lazorchak, A. S.
Right arrow Articles by Zhuang, Y.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
Medline Plus Health Information
*Stem Cells
The Journal of Immunology, 2006, 177: 2495-2504.
Copyright © 2006 by The American Association of Immunologists

E2A Promotes the Survival of Precursor and Mature B Lymphocytes1

Adam S. Lazorchak, Jason Wojciechowski, Meifang Dai and Yuan Zhuang2

Department of Immunology, Duke University Medical Center, Durham, NC 27710

The basic helix-loop-helix transcription factor E2A is an essential regulator of B lymphocyte lineage commitment and is required to activate the expression of numerous B lineage-specific genes. Studies involving ectopic expression of Id proteins, which inhibit E2A as well as other basic helix-loop-helix proteins such as HEB, suggest additional roles of E2A at later stages of B cell development. We use E2A-deficient and E2A and HEB double-deficient pre-B cell lines to directly assess the function of E2A and HEB in B cell development after lineage commitment. We show that, in contrast to the established role of E2A in lineage commitment, elimination of E2A and HEB in pre-B cell lines has only a modest negative impact on B lineage gene expression. However, E2A single and E2A and HEB double-deficient but not HEB single-deficient cell lines show dramatically enhanced apoptosis upon growth arrest. To address the possible role of E2A in the regulation of B cell survival in vivo, we crossed IFN-inducible Cre-transgenic mice to E2A conditional mice. Cre-mediated E2A deletion resulted in a block in bone marrow B cell development and a significant reduction in the proportion and total number of splenic B cells in these mice. We show that Cre-mediated deletion of E2A in adoptively transferred mature B cells results in the rapid depletion of the transferred population within 24 h of Cre induction. These results reveal that E2A is not required to maintain B cell fate but is essential in promoting pre-B and B cell survival.




This article has been cited by other articles:


Home page
Genes Dev.Home page
C. Murre
Developmental trajectories in early hematopoiesis
Genes & Dev., October 15, 2009; 23(20): 2366 - 2370.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
K. Beck, M. M. Peak, T. Ota, D. Nemazee, and C. Murre
Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci
J. Exp. Med., September 28, 2009; 206(10): 2271 - 2284.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Q. Yang, L. Kardava, A. St. Leger, K. Martincic, B. Varnum-Finney, I. D. Bernstein, C. Milcarek, and L. Borghesi
E47 Controls the Developmental Integrity and Cell Cycle Quiescence of Multipotential Hematopoietic Progenitors
J. Immunol., November 1, 2008; 181(9): 5885 - 5894.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Wojciechowski, A. Lai, M. Kondo, and Y. Zhuang
E2A and HEB Are Required to Block Thymocyte Proliferation Prior to Pre-TCR Expression
J. Immunol., May 1, 2007; 178(9): 5717 - 5726.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.